RECBIO-B 02179Hong Kong Stock Exchange

4.4150.00%( +0.000 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
RECBIO-B (02179) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2022-03-31
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE1000057K9

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)14.92M107/112
Net Profit (Last FY)-715.78M112/125
ROE (Last FY)-86.48%104/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
徐浩宇 Executive Director
刘勇 Executive Director
王静 Executive Director
王如伟 Non-Executive Director
张佳鑫 Non-Executive Director
周宏斌 Non-Executive Director
胡厚伟 Non-Executive Director
夏立军 Independent Non-Executive Director
梁国栋 Independent Non-Executive Director
GAO Feng Independent Non-Executive Director
袁铭辉 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-08-25.

About this page

This page shows RECBIO-B (02179) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.